PERBEDAAN DAYA HAMBAT ANTARA KITOSAN DENGAN KOMBINASI ANTIBIOTIK METRONIDAZOL-AMOKSISILIN TERHADAP Actinobacillus Actinomycetemcomitans PENYEBAB PERIODONTITIS AGRESIF
DOI:
https://doi.org/10.30659/medali.v1i1.77Abstrak
Chitosan is a natural biopolymer derived from chitin polysaccharides which has amine functional groups that able to lyse bacteria so it can functioning as an antibacterial. The aim of this study is to determine the difference between the inhibition of chitosan with a combination of antibiotics metronidazole-amoxicillin against Actinobacillus actinomycetemcomitans causes periodontitis aggressive.
This research method used laboratory experimental in vitro by disc diffusion method. The research sample used pure cultures of Actinobacillus actinomycetemcomitans. There were 6 groups of materials, chitosan solution with a concentration of 0.5%, 1%, 1.5%, 2%, distilled water with a combination of antibiotics and six times repetition. The data analysis technique used in this study was the One-Way ANOVA test with a probability of p <0.05, then post hoc test was used to determine the differences effectiveness among variables.
The results showed an average inhibition zone formed on the chitosan solution of 0.5%, 1%, 1.5% and 2% were of 10.53 mm, 15.47 mm, 17.50 mm and 19.35 mm . While the average inhibition zone of 11.03 mm antibiotic combination. In the post hoc test data note that only 0.5% chitosan group with a combination of antibiotics metronidazole-amoxicillin which has no significant difference with p value: 0.371 (p <0.5).
The survey results revealed chitosan solution has the ability to inhibit the growth of Actinobacillus actinomycetemcomitans causes periodontitis aggressive line with increasing concentration. The effectiveness of chitosan with the lowest concentration of 0.5% is almost the same as the effectiveness of a combination of antibiotics and chitosan solution with a concentration of 1%, 1.5% and 2% had a strong antibacterial effectiveness that chitosan can be used as an alternative antibacterial aggressive periodontitis.
Keywords: Chitosan, Combination Antibiotics, Actinobacillus actinomycetemcomitans, aggressive periodontitis
Diterbitkan
Terbitan
Bagian
Lisensi
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

This work is licensed under a Creative Commons Attribution 4.0 International License.